Predictive Oncology Price to Sales Ratio 2010-2025 | POAI
Historical PS ratio values for Predictive Oncology (POAI) over the last 10 years. The current P/S ratio for Predictive Oncology as of July 18, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Predictive Oncology P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-07-18 | 0.79 | 2.54 | |
| 2025-03-31 | 1.52 | $0.31 | 4.88 |
| 2024-12-31 | 0.82 | $0.30 | 2.76 |
| 2024-09-30 | 0.79 | $0.17 | 4.63 |
| 2024-06-30 | 1.04 | $0.28 | 3.66 |
| 2024-03-31 | 2.55 | $0.35 | 7.35 |
| 2023-12-31 | 3.29 | $0.41 | 8.10 |
| 2023-09-30 | 3.20 | $0.45 | 7.12 |
| 2023-06-30 | 4.86 | $0.40 | 12.21 |
| 2023-03-31 | 6.54 | $0.38 | 17.26 |
| 2022-12-31 | 6.14 | $0.41 | 14.83 |
| 2022-09-30 | 7.20 | $0.49 | 14.72 |
| 2022-06-30 | 8.20 | $0.47 | 17.50 |
| 2022-03-31 | 19.54 | $0.50 | 39.01 |
| 2021-12-31 | 19.04 | $0.56 | 34.07 |
| 2021-09-30 | 26.60 | $0.88 | 30.33 |
| 2021-06-30 | 26.20 | $1.42 | 18.44 |
| 2021-03-31 | 24.20 | $1.66 | 14.61 |
| 2020-12-31 | 14.64 | $2.72 | 5.39 |
| 2020-09-30 | 16.28 | $4.65 | 3.50 |
| 2020-06-30 | 32.80 | $7.33 | 4.48 |
| 2020-03-31 | 31.50 | $7.91 | 3.98 |
| 2019-12-31 | 52.20 | $9.94 | 5.25 |
| 2019-09-30 | 101.00 | $12.38 | 8.16 |
| 2019-06-30 | 149.60 | $14.03 | 10.66 |
| 2019-03-31 | 150.00 | $19.12 | 7.85 |
| 2018-12-31 | 123.80 | $23.11 | 5.36 |
| 2018-09-30 | 212.00 | $25.17 | 8.42 |
| 2018-06-30 | 226.00 | $25.09 | 9.01 |
| 2018-03-31 | 220.00 | $22.52 | 9.77 |
| 2017-12-31 | 202.00 | $20.71 | 9.76 |
| 2017-09-30 | 290.80 | $23.68 | 12.28 |
| 2017-06-30 | 294.00 | $26.90 | 10.93 |
| 2017-03-31 | 420.00 | $29.76 | 14.11 |
| 2016-12-31 | 560.00 | $51.25 | 10.93 |
| 2016-09-30 | 825.00 | $270.48 | 3.05 |
| 2016-06-30 | 765.00 | $369.62 | 2.07 |
| 2016-03-31 | 865.00 | $697.58 | 1.24 |
| 2015-12-31 | 14700.00 | $922.83 | 15.93 |
| 2015-09-30 | 16070.00 | $970.04 | 16.57 |
| 2015-06-30 | 15500.00 | $1,524.95 | 10.16 |
| 2015-03-31 | 17250.00 | $1,721.17 | 10.02 |
| 2014-12-31 | 32500.00 | $1,586.00 | 20.49 |
| 2014-09-30 | 41250.00 | $1,513.92 | 27.25 |
| 2014-06-30 | 56250.00 | $1,121.25 | 50.17 |
| 2014-03-31 | 69375.00 | $596.96 | 116.21 |
| 2013-12-31 | 101250.00 | $485.87 | 208.39 |
| 2013-09-30 | 119250.00 | $288.07 | 413.96 |
| 2013-06-30 | 56250.00 | $21.81 | 2578.71 |
| 2013-03-31 | 53250.00 | $17.90 | 2975.37 |
| 2012-12-31 | 45000.00 | $15.46 | 2910.39 |
| 2012-09-30 | 28125.00 | $24.12 | 1166.15 |
| 2012-06-30 | 24375.00 | $24.63 | 989.57 |
| 2012-03-31 | 18750.00 | $22.87 | 819.80 |
| 2011-12-31 | 105000.00 | $19.39 | 5413.87 |
| 2011-09-30 | 131250.00 | $4.29 | 30575.93 |
| 2011-06-30 | 33750.00 | $0.53 | 63281.25 |
| 2011-03-31 | 36000.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.130B | 58.69 |
| Doximity (DOCS) | United States | $11.290B | 52.27 |
| Hims & Hers Health (HIMS) | United States | $11.277B | 117.16 |
| Tempus AI (TEM) | United States | $10.557B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.349B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.741B | 58.45 |
| Hinge Health (HNGE) | United States | $3.664B | 0.00 |
| Privia Health (PRVA) | United States | $2.391B | 163.42 |
| Schrodinger (SDGR) | United States | $1.574B | 0.00 |
| Phreesia (PHR) | United States | $1.516B | 0.00 |
| Enovis (ENOV) | United States | $1.502B | 8.37 |
| Clover Health Investments (CLOV) | United States | $1.496B | 0.00 |
| 10x Genomics (TXG) | United States | $1.496B | 0.00 |
| Azenta (AZTA) | United States | $1.427B | 66.30 |
| Omnicell (OMCL) | United States | $1.259B | 22.21 |
| Evolent Health (EVH) | United States | $1.119B | 95.30 |
| Claritev (CTEV) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.541B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.462B | 0.00 |
| Talkspace (TALK) | United States | $0.415B | 124.00 |
| TruBridge (TBRG) | United States | $0.336B | 746.33 |
| Outset Medical (OM) | United States | $0.309B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.280B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| CapsoVision (CV) | United States | $0.211B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.156B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.85 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |